Obesity is a complex, diverse, and multifactorial disease that has become a significant public health concern. It is a modifiable risk factor for developing type 2 diabetes (T2D). The current classification systems rely on anthropometric measurements, such as body mass index (BMI), which cannot capture the physiopathological diversity of this disease. This study aimed to analyze the metabolic signatures of obesity and diabetes using 1H-nuclear magnetic resonance (NMR). Obese patients with BMI ≥ 25 kg/m2 (according to the Asian cut-off value) with different diabetes status scheduled to undergo metabolic-bariatric surgery at three hospitals were prospectively recruited for this study. Plasma samples of 111 obese patients and 26 healthy controls were analyzed by 1H-NMR. When compared among groups with different diabetes statuses, four clusters with no differences in BMI but different metabolomics profiles were obtained. These clusters highlight intricate metabolic relationships associated with obesity and diabetes. This study demonstrated the benefits of using precision techniques like 1H-NMR to better early detection, substantially decreasing the risk of developing T2D and its related complications. This study is the first to report on metabolic markers and altered metabolic profiles of T2D and prediabetes among obese Malaysians with a BMI cut-off value for the Asian population.

Keywords

1H-NMR; BMI; diabetes; metabolomics; obesity; prediabetes.
 

1. Abboud, K. Y., Reis, S. K., Martelli, M. E., Zordão, O. P., Tannihão, F., de Souza, A. Z. Z., Assalin, H. B., Guadagnini, D., Rocha, G. Z., Saad, M. J. A., & others. (2019). Oral glutamine supplementation reduces obesity, pro-inflammatory markers, and improves insulin sensitivity in DIO Wistar rats and reduces waist circumference in overweight and obese humans. Nutrients, 11(3), 536. https://doi.org/10.3390/nu11030536
2. Ahmed, K., Choi, H.-N., & Yim, J.-E. (2023). The impact of taurine on obesity-induced diabetes mellitus: Mechanisms underlying its effect. Endocrinology and Metabolism, 38(4), 482–492. https://doi.org/10.3803/EnM.2023.1674
3. Akhtar, S., Nasir, J. A., Ali, A., Asghar, M., Majeed, R., & Sarwar, A. (2022). Prevalence of type-2 diabetes and prediabetes in Malaysia: A systematic review and meta-analysis. PLoS ONE, 17(3), e0263139. https://doi.org/10.1371/journal.pone.0263139
4. Alves, A., Bassot, A., Bulteau, A.-L., Pirola, L., & Morio, B. (2019). Glycine metabolism and its alterations in obesity and metabolic diseases. Nutrients, 11(6), 1356. https://doi.org/10.3390/nu11061356
5. American Diabetes Association Professional Practice Committee. (2022). 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2022. Diabetes Care, 45(Supplement_1), S17–S38. https://doi.org/10.2337/dc22-S002
6. Arefhosseini, S., Roshanravan, N., Tutunchi, H., Rostami, S., Khoshbaten, M., & Ebrahimi-Mameghani, M. (2023). Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease. Frontiers in Nutrition, 10, 1092544. https://doi.org/10.3389/fnut.2023.1092544
7. Barlow, J. P., Karstoft, K., Vigelsø, A., Gram, M., Helge, J. W., Dela, F., Pappan, K., O’Neil, D., Dunn, W., & Solomon, T. P. J. (2020). Beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from INS-1 832/3 cells by mediating mitochondrial energy metabolism. Metabolism Open, 7, 100053. https://doi.org/10.1016/j.metop.2020.100053
8. Barrea, L., Annunziata, G., Muscogiuri, G., Di Somma, C., Laudisio, D., Maisto, M., de Alteriis, G., Tenore, G. C., Colao, A., & Savastano, S. (2018). Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients, 10(12), 1971. https://doi.org/10.3390/nu10121971
9. Billoir, E., Navratil, V., & Blaise, B. J. (2015). Sample size calculation in metabolic phenotyping studies. Briefings in Bioinformatics, 16(5), 813–819. https://doi.org/10.1093/bib/bbu051
10. Chen, J., Mangelinckx, S., Adams, A., Wang, Z.-T., Li, W.-L., & De Kimpe, N. (2015). Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications. Natural Product Communications, 10(1), 187–200. https://doi.org/10.1177/1934578X1501000140
11. Chen, W., Liu, R., Zhu, X., Lu, Q., Yang, H., & Liu, R. (2024). Microbial phenolic metabolites 3-(3′,4′-dihydroxyphenyl)propanoic acid and 3′,4′-dihydroxyphenylacetic acid prevent obesity in mice fed with high-fat diet. Food Science and Human Wellness, 13(1), 327–338. https://doi.org/10.1016/j.fshw.2023.02.025
12. Cheng, S., Rhee, E. P., Larson, M. G., Lewis, G. D., McCabe, E. L., Shen, D., Palma, M. J., Roberts, L. D., Dejam, A., Souza, A. L., & others. (2012). Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation, 125(18), 2222–2231. https://doi.org/10.1161/CIRCULATIONAHA.111.067884
13. Clish, C. B. (2015). Metabolomics: An emerging but powerful tool for precision medicine. Cold Spring Harbor Molecular Case Studies, 1(1), a000588. https://doi.org/10.1101/mcs.a000588
14. Croze, M. L., & Soulage, C. O. (2013). Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie, 95(10), 1811–1827. https://doi.org/10.1016/j.biochi.2013.05.011
15. Croze, M. L., Géloën, A., & Soulage, C. O. (2015). Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: Benefits of a dietary myo-inositol supplementation. British Journal of Nutrition, 113(12), 1862–1875. https://doi.org/10.1017/S000711451500119X
16. Dehghan, P., Farhangi, M. A., Nikniaz, L., Nikniaz, Z., & Asghari-Jafarabadi, M. (2020). Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta-analysis. Obesity Reviews, 21(6), e12993. https://doi.org/10.1111/obr.12993
17. Emwas, A.-H., Roy, R., McKay, R. T., Tenori, L., Saccenti, E., Gowda, G. A. N., Raftery, D., Alahmari, F., Jaremko, L., Jaremko, M., & others. (2019). NMR spectroscopy for metabolomics research. Metabolites, 9(7), 123. https://doi.org/10.3390/metabo9070123
18. Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., & others. (2013). Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes, 62(2), 639–648. https://doi.org/10.2337/db12-0495
19. Ganasegeran, K., Hor, C. P., Jamil, M. F. A., Suppiah, P. D., Noor, J. M., Hamid, N. A., Chuan, D. R., Manaf, M. R. A., Ch’ng, A. S. H., & Looi, I. (2021). Mapping the scientific landscape of diabetes research in Malaysia (2000–2018): A systematic scientometrics study. International Journal of Environmental Research and Public Health, 18(1), 318. https://doi.org/10.3390/ijerph18010318
20. Grant, B., Sandelson, M., Agyemang-Prempeh, B., & Zalin, A. (2021). Managing obesity in people with type 2 diabetes. Clinical Medicine, 21(4), e327–e331. https://doi.org/10.7861/clinmed.2021-0268
21. Guo, X., Ou, T., Yang, X., Song, Q., Zhu, L., Mi, S., Zhang, J., Zhang, Y., Chen, W., & Guo, J. (2024). Untargeted metabolomics based on ultra-high performance liquid chromatography-mass spectrometry/MS reveals the lipid-lowering mechanism of taurine in hyperlipidemia mice. Frontiers in Nutrition, 11, 1367589. https://doi.org/10.3389/fnut.2024.1367589
22. Halama, A., Aye, M. M., Dargham, S. R., Kulinski, M., Suhre, K., & Atkin, S. L. (2019). Metabolomics of dynamic changes in insulin resistance before and after exercise in PCOS. Frontiers in Endocrinology, 10, 116. https://doi.org/10.3389/fendo.2019.00116
23. Hernandez-Baixauli, J., Quesada-Vázquez, S., Mariné-Casadó, R., Gil Cardoso, K., Caimari, A., Del Bas, J. M., Escoté, X., & Baselga-Escudero, L. (2020). Detection of early disease risk factors associated with metabolic syndrome: A new era with the NMR metabolomics assessment. Nutrients, 12(3), 806. https://doi.org/10.3390/nu12030806
24. Hernandez-Castillo, C., & Shuck, S. C. (2021). Diet and obesity-induced methylglyoxal production and links to metabolic disease. Chemical Research in Toxicology, 34(12), 2424–2440. https://doi.org/10.1021/acs.chemrestox.1c00224
25. Ho, J. E., Larson, M. G., Ghorbani, A., Cheng, S., Chen, M.-H., Keyes, M., Rhee, E. P., Clish, C. B., Vasan, R. S., Gerszten, R. E., & others. (2016). Metabolomic profiles of body mass index in the Framingham Heart Study reveal distinct cardiometabolic phenotypes. PLoS ONE, 11(3), e0148361. https://doi.org/10.1371/journal.pone.0148361
26. Huang, Y., Zhu, Z., Huang, Z., & Zhou, J. (2023). Elevated serum trimethylamine oxide levels as potential biomarker for diabetic kidney disease. Endocrine Connections, 12(3), e220542. https://doi.org/10.1530/EC-22-0542
27. Imamura, M., & Maeda, S. (2024). Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine. Journal of Diabetes Investigation, 15(4), 410–422. https://doi.org/10.1111/jdi.14131
28. Institute for Public Health (IKU). (2024). National Health and Morbidity Survey (NHMS) 2023: Non-communicable diseases and healthcare demand: Technical report. Institute for Public Health.
29. Jaworska, K., Kuś, M., & Ufnal, M. (2025). TMAO and diabetes: From the gut feeling to the heart of the problem. Nutrition & Diabetes, 15(1), 21. https://doi.org/10.1038/s41387-025-00361-y
30. Jin, Q., & Ma, R. C. W. (2021). Metabolomics in diabetes and diabetic complications: Insights from epidemiological studies. Cells, 10(11), 2832. https://doi.org/10.3390/cells10112832
31. Jung, J., Park, W. Y., Kim, Y. J., Kim, M., Choe, M., Jin, K., Seo, J. H., & Ha, E. (2022). 3-Hydroxybutyrate ameliorates the progression of diabetic nephropathy. Antioxidants, 11(2), 381. https://doi.org/10.3390/antiox11020381
32. Kamiya, T., & Shirai, A. (2006). Anti-obesity agent (U.S. Patent Application No. US20060264498A1). U.S. Patent and Trademark Office.
33. Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011). Fatty acids, obesity, and insulin resistance: Time for a reevaluation. Diabetes, 60(10), 2441–2449. https://doi.org/10.2337/db11-0425
34. Kawaguchi, T., Nakano, D., Oriishi, T., & Torimura, T. (2018). Effects of isomaltulose on insulin resistance and metabolites in patients with non-alcoholic fatty liver disease: A metabolomic analysis. Molecular Medicine Reports, 18(2), 2033–2042. https://doi.org/10.3892/mmr.2018.9141
35. Kenéz, Á., Warnken, T., & Feige, K. (2018). Lower plasma trans-4-hydroxyproline and methionine sulfoxide levels are associated with insulin dysregulation in horses. BMC Veterinary Research, 14(1), 146. https://doi.org/10.1186/s12917-018-1473-2
36. Khanna, D., Khanna, S., Khanna, P., Kahar, P., & Patel, B. M. (2022). Obesity: A chronic low-grade inflammation and its markers. Cureus, 14(3), e22711. https://doi.org/10.7759/cureus.22711
37. Kistner, S., Rist, M. J., Döring, M., Dörr, C., Neumann, R., Härtel, S., & Bub, A. (2020). An NMR-based approach to identify urinary metabolites associated with acute physical exercise and cardiorespiratory fitness in healthy humans—Results of the KarMeN study. Metabolites, 10(6), 212. https://doi.org/10.3390/metabo10060212
38. Klein, S., Gastaldelli, A., Yki-Järvinen, H., & Scherer, P. E. (2022). Why does obesity cause diabetes? Cell Metabolism, 34(1), 11–20. https://doi.org/10.1016/j.cmet.2021.12.012
39. Layman, D. K. (2003). The role of leucine in weight loss diets and glucose homeostasis. The Journal of Nutrition, 133(1), 261S–267S. https://doi.org/10.1093/jn/133.1.261S
40. Lee, C. C., Watkins, S. M., Lorenzo, C., Wagenknecht, L. E., Il’yasova, D., Chen, Y.-D. I., Haffner, S. M., & Hanley, A. J. (2016). Branched-chain amino acids and insulin metabolism: The Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care, 39(4), 582–588. https://doi.org/10.2337/dc15-2284
41. Lee, S. J., Park, Y. S., Kim, Y.-J., Han, S.-U., Hwang, G.-S., Han, Y., Heo, Y., Ha, E., & Ha, T. K. (2021). Changes in trimethylamine-N-oxide levels in obese patients following laparoscopic Roux-en-Y gastric bypass or sleeve gastrectomy in a Korean Obesity Surgical Treatment Study (KOBESS). Journal of Clinical Medicine, 10(21), 5091. https://doi.org/10.3390/jcm10215091
42. Leiherer, A., Muendlein, A., Mink, S., Mader, A., Saely, C. H., Festa, A., Fraunberger, P., & Drexel, H. (2024). Machine learning approach to metabolomic data predicts type 2 diabetes mellitus incidence. International Journal of Molecular Sciences, 25(10), 5331. https://doi.org/10.3390/ijms25105331
43. Li, M., Reynolds, C. M., Sloboda, D. M., Gray, C., & Vickers, M. H. (2013). Effects of taurine supplementation on hepatic markers of inflammation and lipid metabolism in mothers and offspring in the setting of maternal obesity. PLoS ONE, 8(10), e76961. https://doi.org/10.1371/journal.pone.0076961
44. Li, X., Chen, Y., Liu, J., Yang, G., Zhao, J., Liao, G., Shi, M., Yuan, Y., He, S., Lu, Y., & others. (2012). Serum metabolic variables associated with impaired glucose tolerance induced by high-fat-high-cholesterol diet in Macaca mulatta. Experimental Biology and Medicine, 237(11), 1310–1321. https://doi.org/10.1258/ebm.2012.012170
45. Lin, H.-T., Cheng, M.-L., Lo, C.-J., Lin, G., Lin, S.-F., Yeh, J.-T., Ho, H.-Y., Lin, J.-R., & Liu, F.-C. (2019). 1H nuclear magnetic resonance (NMR)-based cerebrospinal fluid and plasma metabolomic analysis in type 2 diabetic patients and risk prediction for diabetic microangiopathy. Journal of Clinical Medicine, 8(6), 874. https://doi.org/10.3390/jcm8060874
46. Lin, W. (2024). The association between body mass index and glycohemoglobin (HbA1c) in the US population’s diabetes status. International Journal of Environmental Research and Public Health, 21(4), 517. https://doi.org/10.3390/ijerph21040517
47. Luo, B., Xu, W., Ye, D., Bai, X., Wu, M., Zhang, C., & Shi, R. (2024). Association between glycated hemoglobin and the lipid profile at the central Yunnan plateau: A retrospective study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 17, 2975–2981. https://doi.org/10.2147/DMSO.S467979
48. Lynch, C. J., & Adams, S. H. (2014). Branched-chain amino acids in metabolic signalling and insulin resistance. Nature Reviews Endocrinology, 10(12), 723–736. https://doi.org/10.1038/nrendo.2014.171
49. Magliano, D., & Boyko, E. J. (2021). IDF Diabetes Atlas (10th ed.). International Diabetes Federation.
50. Mahendran, Y., Vangipurapu, J., Cederberg, H., Stancáková, A., Pihlajamäki, J., Soininen, P., Kangas, A. J., Paananen, J., Civelek, M., Saleem, N. K., & others. (2013). Association of ketone body levels with hyperglycemia and type 2 diabetes in 9,398 Finnish men. Diabetes, 62(10), 3618–3626. https://doi.org/10.2337/db12-1362
51. Mashayekh-Amiri, S., Mohammad-Alizadeh-Charandabi, S., Abdolalipour, S., & Mirghafourvand, M. (2022). Myo-inositol supplementation for prevention of gestational diabetes mellitus in overweight and obese pregnant women: A systematic review and meta-analysis. Diabetology & Metabolic Syndrome, 14(1), 93. https://doi.org/10.1186/s13098-022-00863-8
52. Mihuta, M. S., Paul, C., Borlea, A., Roi, C. M., Pescari, D., Velea-Barta, O.-A., Mozos, I., & Stoian, D. (2023). Connections between serum trimethylamine N-oxide (TMAO), a gut-derived metabolite, and vascular biomarkers evaluating arterial stiffness and subclinical atherosclerosis in children with obesity. Frontiers in Endocrinology, 14, 1253584. https://doi.org/10.3389/fendo.2023.1253584
53. Ministry of Health Malaysia. (2020). Clinical Practice Guideline—Management of Type 2 Diabetes Mellitus (6th ed.). Ministry of Health Malaysia.
54. Nakao, T., Otaki, S., Kominami, Y., Watanabe, S., Ito, M., Aizawa, T., Akahori, Y., & Ushio, H. (2023). L-Fucose suppresses lipid accumulation via the AMPK pathway in 3T3-L1 adipocytes. Nutrients, 15(2), 503. https://doi.org/10.3390/nu15020503
55. Newbern, D., Gumus Balikcioglu, P., Balikcioglu, M., Bain, J., Muehlbauer, M., Stevens, R., Ilkayeva, O., Dolinsky, D., Armstrong, S., Irizarry, K., & others. (2014). Sex differences in biomarkers associated with insulin resistance in obese adolescents: Metabolomic profiling and principal components analysis. The Journal of Clinical Endocrinology & Metabolism, 99(12), 4730–4739. https://doi.org/10.1210/jc.2014-2617
56. Newgard, C. B. (2012). Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metabolism, 15(5), 606–614. https://doi.org/10.1016/j.cmet.2012.01.024
57. Nishitani, S., Fukuhara, A., Tomita, I., Kume, S., Shin, J., Okuno, Y., Otsuki, M., Maegawa, H., & Shimomura, I. (2022). Ketone body 3-hydroxybutyrate enhances adipocyte function. Scientific Reports, 12(1), 10080. https://doi.org/10.1038/s41598-022-14302-3
58. Osborn, L. J., Schultz, K., Massey, W., DeLucia, B., Choucair, I., Varadharajan, V., Banerjee, R., Fung, K., Horak, A. J., Orabi, D., & others. (2022). A gut microbial metabolite of dietary polyphenols reverses obesity-driven hepatic steatosis. Proceedings of the National Academy of Sciences, 119(41), e2202934119. https://doi.org/10.1073/pnas.2202934119
59. O’Sullivan, A., Gibney, M. J., & Brennan, L. (2011). Dietary intake patterns are reflected in metabolomic profiles: Potential role in dietary assessment studies. The American Journal of Clinical Nutrition, 93(2), 314–321. https://doi.org/10.3945/ajcn.110.000141
60. Ozcariz, E., Guardiola, M., Amigó, N., Valdés, S., Oualla-Bachiri, W., Rehues, P., Rojo-Martinez, G., & Ribalta, J. (2024). H-NMR metabolomics identifies three distinct metabolic profiles differentially associated with cardiometabolic risk in patients with obesity in the [email protected] cohort. Cardiovascular Diabetology, 23(1), 402. https://doi.org/10.1186/s12933-024-02497-8
61. Palmer, N. D., Stevens, R. D., Antinozzi, P. A., Anderson, A., Bergman, R. N., Wagenknecht, L. E., Newgard, C. B., & Bowden, D. W. (2015). Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. The Journal of Clinical Endocrinology & Metabolism, 100(3), E463–E468. https://doi.org/10.1210/jc.2014-3618
62. Pawan, G. L., & Semple, S. J. (1983). Effect of 3-hydroxybutyrate in obese subjects on very-low-energy diets and during therapeutic starvation. The Lancet, 321(8314), 15–17. https://doi.org/10.1016/S0140-6736(83)91562-7
63. Peddinti, G., Cobb, J., Yengo, L., Froguel, P., Kravić, J., Balkau, B., Tuomi, T., Aittokallio, T., Groop, L., & others. (2017). Early metabolic markers identify potential targets for the prevention of type 2 diabetes. Diabetologia, 60(9), 1740–1750. https://doi.org/10.1007/s00125-017-4325-0
64. Petrus, P., Lecoutre, S., Dollet, L., Wiel, C., Sulen, A., Gao, H., Tavira, B., Laurencikiene, J., Rooyackers, O., Checa, A., & others. (2020). Glutamine links obesity to inflammation in human white adipose tissue. Cell Metabolism, 31(2), 375–390. https://doi.org/10.1016/j.cmet.2019.11.009
65. Reichard, G. A., Skutches, C. L., Hoeldtke, R. D., & Owen, O. E. (1986). Acetone metabolism in humans during diabetic ketoacidosis. Diabetes, 35(6), 668–674. https://doi.org/10.2337/diab.35.6.668
66. Ruze, R., Liu, T., Zou, X., Song, J., Chen, Y., Xu, R., Yin, X., & Xu, Q. (2023). Obesity and type 2 diabetes mellitus: Connections in epidemiology, pathogenesis, and treatments. Frontiers in Endocrinology, 14, 1161521. https://doi.org/10.3389/fendo.2023.1161521
67. Sam, S., & Mazzone, T. (2014). Adipose tissue changes in obesity and the impact on metabolic function. Translational Research, 164(4), 284–292. https://doi.org/10.1016/j.trsl.2014.05.013
68. Saparuddin, F., Mohd Nawi, M. N., Ahmad Zamri, L., Mansor, F., Md Noh, M. F., Omar, M. A., Abdul Aziz, N. S., Wahab, N. A., Mediani, A., Rajab, N. F., & others. (2024). Metabolite, biochemical, and dietary intake alterations associated with lifestyle interventions in obese and overweight Malaysian women. Nutrients, 16(20), 3501. https://doi.org/10.3390/nu16203501
69. Schumacher, D., Morgenstern, J., Oguchi, Y., Volk, N., Kopf, S., Groener, J. B., Nawroth, P. P., Fleming, T., & Freichel, M. (2018). Compensatory mechanisms for methylglyoxal detoxification in experimental & clinical diabetes. Molecular Metabolism, 18, 143–152. https://doi.org/10.1016/j.molmet.2018.09.006
70. Shahisavandi, M., Wang, K., Ghanbari, M., & Ahmadizar, F. (2023). Exploring metabolomic patterns in type 2 diabetes mellitus and response to glucose-lowering medications—Review. Genes, 14(7), 1464. https://doi.org/10.3390/genes14071464
71. Sikes, K. J., McConnell, A., Serkova, N., Cole, B., & Frisbie, D. (2022). Untargeted metabolomics analysis identifies creatine, myo-inositol, and lipid pathway modulation in a murine model of tendinopathy. Journal of Orthopaedic Research, 40(4), 965–976. https://doi.org/10.1002/jor.25119
72. Singla, P., Bardoloi, A., & Parkash, A. A. (2010). Metabolic effects of obesity: A review. World Journal of Diabetes, 1(3), 76–88. https://doi.org/10.4239/wjd.v1.i3.76
73. Stancáková, A., Civelek, M., Saleem, N. K., Soininen, P., Kangas, A. J., Cederberg, H., Paananen, J., Pihlajamäki, J., Bonnycastle, L. L., Morken, M. A., & others. (2012). Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9369 Finnish men. Diabetes, 61(7), 1895–1902. https://doi.org/10.2337/db11-1388
74. Sun, Q., Wang, J., Wang, H., Yu, H., Wan, K., Ma, F., & Wang, R. (2025). Effect of long-term taurine supplementation on the lipid and glycaemic profile in adults with overweight or obesity: A systematic review and meta-analysis. Nutrients, 17(1), 55. https://doi.org/10.3390/nu17010055
75. Tai, E. S., Tan, M. L. S., Stevens, R. D., Low, Y. L., Muehlbauer, M. J., Goh, D. L. M., Ilkayeva, O. R., Wenner, B. R., Bain, J. R., Lee, J. J. M., & others. (2010). Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia, 53(4), 757–767. https://doi.org/10.1007/s00125-009-1636-6
76. Takashina, C., Tsujino, I., Watanabe, T., Sakaue, S., Ikeda, D., Yamada, A., Sato, T., Ohira, H., Otsuka, Y., Oyama-Manabe, N., & others. (2016). Associations among the plasma amino acid profile, obesity, and glucose metabolism in Japanese adults with normal glucose tolerance. Nutrition & Metabolism, 13(1), 5. https://doi.org/10.1186/s12986-016-0065-2
77. Tan, J.K., Zakaria, S. N. A., Gunasekaran, G., Abdul Sani, N. F., Nasaruddin, M. L., Jaafar, F., Abu Bakar, Z. H., Amir Hamzah, A. I. Z., Nor Aripin, K. N., Mohd Rani, M. D., & others. (2023). Metabolomics profiling of age-associated metabolites in Malay population. Oxidative Medicine and Cellular Longevity, 2023, 4416410. https://doi.org/10.1155/2023/4416410
78. Thalacker-Mercer, A. E., Ingram, K. H., Guo, F., Ilkayeva, O., Newgard, C. B., & Garvey, W. T. (2014). BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans. Diabetes, 63(2), 791–800. https://doi.org/10.2337/db13-0211
79. Tobias, D. K., Hazra, A., Lawler, P. R., Chandler, P. D., Chasman, D. I., Buring, J. E., Lee, I.-M., Cheng, S., Manson, J. E., & Mora, S. (2020). Circulating branched-chain amino acids and long-term risk of obesity-related cancers in women. Scientific Reports, 10(1), 16534. https://doi.org/10.1038/s41598-020-73133-7
80. Trautman, M. E., Green, C. L., MacArthur, M. R., Chaiyakul, K., Alam, Y. H., Yeh, C. Y., Babygirija, R., James, I., Gilpin, M., Zelenovskiy, E., & others. (2024). Dietary isoleucine content defines the metabolic and molecular response to a Western diet. bioRxiv. https://doi.org/10.1101/2024.03.04.583344
81. Tulipani, S., Palau-Rodriguez, M., Miñarro Alonso, A., Cardona, F., Marco-Ramell, A., Zonja, B., Lopez de Alda, M., Muñoz-Garach, A., Sanchez-Pla, A., Tinahones, F. J., & others. (2016). Biomarkers of morbid obesity and prediabetes by metabolomic profiling of human discordant phenotypes. Clinica Chimica Act, 463, 53–61. https://doi.org/10.1016/j.cca.2016.10.006
82. Tzang, C.-C., Chi, L.-Y., Lin, L.-H., Lin, T.-Y., Chang, K.-V., Wu, W.-T., & Özçakar, L. (2024). Taurine reduces the risk for metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Nutrition & Diabetes, 14(1), 29. https://doi.org/10.1038/s41387-024-00287-x
83. Vemula, H., Kitase, Y., Ayon, N. J., Bonewald, L., & Gutheil, W. G. (2017). Gaussian and linear deconvolution of LC-MS/MS chromatograms of the eight aminobutyric acid isomers. Analytical Biochemistry, 516, 75–85. https://doi.org/10.1016/j.ab.2016.10.019
84. Wang, P., Wang, R., Zhao, W., Zhao, Y., Wang, D., Zhao, S., Ge, Z., Ma, Y., & Zhao, X. (2025). Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation. Gut Microbes, 17(1), 2446391. https://doi.org/10.1080/19490976.2025.2446391
85. Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., & others. (2011). Metabolite profiles and the risk of developing diabetes. Nature Medicine, 17(4), 448–453. https://doi.org/10.1038/nm.2307
86. Wijayatunga, N. N., Sams, V. G., Dawson, J. A., Mancini, M. L., Mancini, G. J., & Moustaid-Moussa, N. (2018). Roux-en-Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity. Diabetes/Metabolism Research and Reviews, 34(8), e3045. https://doi.org/10.1002/dmrr.3045
87. Wu, C., Yang, F., Zhong, H., Hong, J., Lin, H., Zong, M., Ren, H., Zhao, S., Chen, Y., Shi, Z., & others. (2024). Obesity-enriched gut microbe degrades myo-inositol and promotes lipid absorption. Cell Host & Microbe, 32(8), 1301–1314.e9. https://doi.org/10.1016/j.chom.2024.06.014
88. Wu, G., Niu, M., Tang, W., Hu, J., Wei, G., He, Z., Chen, Y., Jiang, Y., & Chen, P. (2018). L-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice. Journal of Translational Medicine, 16(1), 344. https://doi.org/10.1186/s12967-018-1721-z
89. Würtz, P., Soininen, P., Kangas, A. J., Rönnemaa, T., Lehtimäki, T., Kähönen, M., Viikari, J. S., Raitakari, O. T., & Ala-Korpela, M. (2013). Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care, 36(3), 648–655. https://doi.org/10.2337/dc12-0895
90. Xu, F., Tavintharan, S., Sum, C. F., Woon, K., Lim, S. C., & Ong, C. N. (2013). Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics. The Journal of Clinical Endocrinology & Metabolism, 98(6), E1060–E1065. https://doi.org/10.1210/jc.2012-4122
91. Yi, X., Yang, Y., Li, T., Li, M., Yao, T., Hu, G., Wan, G., & Chang, B. (2023). Signaling metabolite $\beta$-aminoisobutyric acid as a metabolic regulator, biomarker, and potential exercise pill. Frontiers in Endocrinology, 14, 1192458. https://doi.org/10.3389/fendo.2023.1192458
92. Yousri, N. A., Suhre, K., Yassin, E., Al-Shakaki, A., Robay, A., Elshafei, M., Chidiac, O., Hunt, S. C., Crystal, R. G., & Fakhro, K. A. (2022). Metabolic and metabo-clinical signatures of type 2 diabetes, obesity, retinopathy, and dyslipidemia. Diabetes, 71(2), 184–205. https://doi.org/10.2337/db21-0490
93. Yu, D., Richardson, N. E., Green, C. L., Spicer, A. B., Murphy, M. E., Flores, V., Jang, C., Kasza, I., Nikodemova, M., Wakai, M. H., & others. (2021). The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine. Cell Metabolism, 33(5), 905–922.e6. https://doi.org/10.1016/j.cmet.2021.03.012
94. Zarezadeh, M., Dehghani, A., Faghfouri, A. H., Radkhah, N., Naemi Kermanshahi, M., Hamedi Kalajahi, F., Mohammadzadeh Honarvar, N., Ghoreishi, Z., Ostadrahimi, A., & Ebrahimi Mamaghani, M. (2022). Inositol supplementation and body mass index: A systematic review and meta-analysis of randomized clinical trials. Obesity Science & Practice, 8(3), 387–397. https://doi.org/10.1002/osp4.569
95. Zhang, Q., Cheng, J., Jiang, X., Tang, J., Zhu, C., Chen, H., & Laghi, L. (2023). Metabolomic characteristics of cecum contents in high-fat-diet-induced obese mice intervened with different fibers. Foods, 12(7), 1403. https://doi.org/10.3390/foods12071403
96. Zhang, Y., Li, Z., Liu, X., Chen, X., Zhang, S., Chen, Y., Chen, J., Chen, J., Wu, F., & Chen, G.-Q. (2023). 3-Hydroxybutyrate ameliorates insulin resistance by inhibiting PPAR$\gamma$ Ser273 phosphorylation in type 2 diabetic mice. Signal Transduction and Targeted Therapy, 8(1), 190. https://doi.org/10.1038/s41392-023-01413-x
97. Zhao, X., Gang, X., Liu, Y., Sun, C., Han, Q., & Wang, G. (2016). Using metabolomic profiles as biomarkers for insulin resistance in childhood obesity: A systematic review. Journal of Diabetes Research, 2016, 8160545. https://doi.org/10.1155/2016/8160545
98. Zheng, J.-S., Lin, M., Imamura, F., Cai, W., Wang, L., Feng, J.-P., Ruan, Y., Tang, J., Wang, F., Yang, H., & others. (2016). Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: A double-blind randomised controlled trial. Scientific Reports, 6(1), 29522. https://doi.org/10.1038/srep29522
99. Zuo, J., Zhang, Y., Wu, Y., Liu, J., Wu, Q., Shen, Y., Jin, L., Wu, M., Ma, Z., & Tong, H. (2022). Sargassum fusiforme fucoidan ameliorates diet-induced obesity through enhancing thermogenesis of adipose tissues and modulating gut microbiota. International Journal of Biological Macromolecules, 216, 728–740. https://doi.org/10.1016/j.ijbiomac.2022.07.031